{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T19:58:28Z","timestamp":1792699108356,"version":"4.5.0"},"reference-count":91,"publisher":"Wiley","issue":"12","license":[{"start":{"date-parts":[[2008,5,13]],"date-time":"2008-05-13T00:00:00Z","timestamp":1210636800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Deutsche Derma Gesell"],"published-print":{"date-parts":[[2008,12]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p>Topical retinoids are important tools in the management of acne because they act against comedones and microcomedones and have direct anti\u2010inflammatory effects. The substances approved for acne treatment comprise tretinoin (<jats:italic>all\u2010trans\u2010retinoic acid<\/jats:italic>),isotretinoin (13\u2010<jats:italic>cis<\/jats:italic> retinoic acid) as well as the synthetic third\u2010generation polyaromatic retinoids adapalene and tazarotene,the latter being approved for acne treatment in the US only.Retinaldehyde is used in cosmetic preparations against acne.<\/jats:p><jats:p>All topical retinoids are effective as single agents in mild to moderate acne but differ in efficacy and tolerability. Tazarotene 0.1% is more effective than tretinoin 0.025% or 0.1% microsphere gel or adapalene 0.1% gel or cream (EBM\u2010level 2c). Adapalene 0.1% is equally effective to tretinoin 0.025% or tretinoin microsphere 0.1% gel or tretinoin 0.05% cream or isotretinoin 0.05% gel (EBM\u2010level 2c). Adapalene 0.1% gel is significantly better tolerated than tazarotene 0.1% gel, tretinoin 0.025% and tretinoin 0.05% gel, tretinoin 0.05% cream,tretinoin microsphere 0.1% gel or isotretinoin 0.05% gel (EBM\u2010level 2c).The safety profile of topical retinoids differs from their systemic counterparts and is related mainly to local adverse effects, such as erythema, dry\u2010ness,itching and stinging.The currently available evidence justifies the use of topical retinoids in most types of acne and during maintenance treatment.<\/jats:p>","DOI":"10.1111\/j.1610-0387.2008.06741.x","type":"journal-article","created":{"date-parts":[[2008,5,13]],"date-time":"2008-05-13T11:11:32Z","timestamp":1210677092000},"page":"1023-1031","source":"Crossref","is-referenced-by-count":70,"title":["Topical retinoids in acne \u2013 an evidence\u2010based overview"],"prefix":"10.1111","volume":"6","author":[{"given":"Anja","family":"Thielitz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed B.","family":"Abdel\u2010Naser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joachim W.","family":"Fluhr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christos C.","family":"Zouboulis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harald","family":"Gollnick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2008,11,25]]},"reference":[{"key":"e_1_2_16_2_2","first-page":"773","article-title":"An ultrastructural study of the effects of topical tretinoin on microcomedones","volume":"14","author":"Lavker RM","year":"1992","journal-title":"Clin Ther"},{"key":"e_1_2_16_3_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.2001.04276.x"},{"key":"e_1_2_16_4_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2007.02190.x"},{"key":"e_1_2_16_5_2","doi-asserted-by":"publisher","DOI":"10.1067\/mjd.2003.618"},{"key":"e_1_2_16_6_2","doi-asserted-by":"publisher","DOI":"10.1067\/S0190-9622(03)01154-X"},{"key":"e_1_2_16_7_2","first-page":"281","article-title":"Mechanism\u2010based treatment of acne vulgaris: the value of combination therapy","volume":"4","author":"Webster G","year":"2005","journal-title":"J Drugs Dermatol"},{"key":"e_1_2_16_8_2","first-page":"169","article-title":"Evidence\u2010based medicine: how to practise and teach EBM","author":"Sackett D","year":"2001","journal-title":"London: Churchill Livingstone"},{"key":"e_1_2_16_9_2","first-page":"41","article-title":"Mechanisms of the come\u2010dolytic and anti\u2010inflammatory properties of topical retinoids","volume":"4","author":"Bikowski JB","year":"2005","journal-title":"J Drugs Dermatol"},{"key":"e_1_2_16_10_2","first-page":"10","article-title":"The mechanism of action of topical retinoids","volume":"75","author":"Kang S","year":"2005","journal-title":"Cutis"},{"issue":"199","key":"e_1_2_16_11_2","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1159\/000051375","article-title":"Antibacterial activity of retinaldehyde against Pro\u2010pionibacterium acnes","volume":"1","author":"Pechere M","year":"1999","journal-title":"Dermatology"},{"key":"e_1_2_16_12_2","doi-asserted-by":"crossref","first-page":"3","DOI":"10.5070\/D394Q2X8F1","article-title":"The potential immunomo\u2010dulatory effects of topical retinoids","volume":"11","author":"Jones DA","year":"2005","journal-title":"Dermatol Online J"},{"key":"e_1_2_16_13_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02850266"},{"key":"e_1_2_16_14_2","first-page":"106","article-title":"Comparison of two concentrations of tretinoin solution in the topical treatment of acne vulgaris","volume":"216","author":"Krishnan G","year":"1976","journal-title":"Practitioner"},{"key":"e_1_2_16_15_2","first-page":"219","article-title":"The retinoic acid derivative Ro 11\u20131430 in Acne vulgaris. A controlled multi\u2010center trial against retinoic acid","volume":"154","author":"Christiansen J","year":"1977","journal-title":"Der-matologica"},{"key":"e_1_2_16_16_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1540-9740.2006.05606.x"},{"key":"e_1_2_16_17_2","doi-asserted-by":"publisher","DOI":"10.1021\/js9604568"},{"key":"e_1_2_16_18_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.1998.1390s2034.x"},{"key":"e_1_2_16_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(98)70139-2"},{"key":"e_1_2_16_20_2","first-page":"152","article-title":"A double\u2010blinded, randomized, vehicle\u2010controlled, multicenter, parallel\u2010group study to assess the safety and efficacy of tretinoin gel microsphere 0.04% in the treatment of acne vulgaris in adults","volume":"80","author":"Berger R","year":"2007","journal-title":"Cutis"},{"key":"e_1_2_16_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2007.06.021"},{"key":"e_1_2_16_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(98)70141-0"},{"key":"e_1_2_16_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(98)70142-2"},{"key":"e_1_2_16_24_2","doi-asserted-by":"crossref","first-page":"555","DOI":"10.2340\/0001555558555557","article-title":"Treatment of acne vulgaris with topically applied erythromycin and tretinoin","volume":"58","author":"Mills OH","year":"1978","journal-title":"Acta Derm Venereol"},{"key":"e_1_2_16_25_2","first-page":"447","article-title":"Efficacy and tolerability of combined topical treatment of acne vulgaris with treti\u2010noin and erythromycin in general practice","volume":"15","author":"Korting HC","year":"1989","journal-title":"Drugs Exp Clin Res"},{"key":"e_1_2_16_26_2","doi-asserted-by":"publisher","DOI":"10.1185\/030079900542759"},{"key":"e_1_2_16_27_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10227-002-2101-2"},{"key":"e_1_2_16_28_2","first-page":"548","article-title":"Retinoic acid cream (Airol cream) and benzoyl\u2010peroxide in the treatment of acne vulgaris","volume":"10","author":"Handojo I","year":"1979","journal-title":"Southeast Asian J Trop Med Public Health"},{"key":"e_1_2_16_29_2","first-page":"295","article-title":"The stability of treti\u2010noin in tretinoin gel microsphere 0.1%","volume":"70","author":"Nyirady J","year":"2002","journal-title":"Cutis"},{"key":"e_1_2_16_30_2","first-page":"167","article-title":"Compared efficacy and safety of tretinoin 0.1% microsphere gel alone and in combination with benzoyl peroxide 6% cleanser for the treatment of acne vulgaris","volume":"72","author":"Shalita AR","year":"2003","journal-title":"Cutis"},{"key":"e_1_2_16_31_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2000.03701.x"},{"key":"e_1_2_16_32_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.1998.tb00974.x"},{"key":"e_1_2_16_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2005.04.046"},{"key":"e_1_2_16_34_2","first-page":"607","article-title":"Clinical safety and efficacy studies of a novel formulation combining 1.2% clindamycin phosphate and 0.025% tretinoin for the treatment of acne vulgaris","volume":"6","author":"Schlessinger J","year":"2007","journal-title":"J Drugs Dermatol"},{"key":"e_1_2_16_35_2","first-page":"611","article-title":"Comparison of clin\u2010damycin\/benzoyl peroxide, tretinoin plus clindamycin, and the combination of clindamycin\/benzoyl peroxide and tretinoin plus clindamycin in the treatment of acne vulgaris: a randomized, blinded study","volume":"4","author":"Bowman S","year":"2005","journal-title":"J Drugs Dermatol"},{"key":"e_1_2_16_36_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(87)70200-X"},{"key":"e_1_2_16_37_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-4362.1998.00254.x"},{"key":"e_1_2_16_38_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.2002.04873.x"},{"key":"e_1_2_16_39_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2230.1992.tb00196.x"},{"key":"e_1_2_16_40_2","doi-asserted-by":"publisher","DOI":"10.1159\/000018255"},{"key":"e_1_2_16_41_2","doi-asserted-by":"publisher","DOI":"10.1080\/09546630260199460"},{"key":"e_1_2_16_42_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.1998.1390s2048.x"},{"key":"e_1_2_16_43_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.1998.1390s2041.x"},{"key":"e_1_2_16_44_2","first-page":"10","article-title":"Randomized controlled trial of the tolerability, safety, and efficacy of adapalene gel 0.1% and tretinoin microsphere gel 0.1% for the treatment of acne vulgaris","volume":"68","author":"Thiboutot D","year":"2001","journal-title":"Cutis"},{"key":"e_1_2_16_45_2","doi-asserted-by":"publisher","DOI":"10.1159\/000018117"},{"key":"e_1_2_16_46_2","first-page":"350","article-title":"Randomised, controlled trial of the efficacy and safety of adapalene gel 0.1% and tretinoin cream 0.05% in patients with acne vulgaris","volume":"12","author":"Cunliffe WJ","year":"2002","journal-title":"Eur J Dermatol"},{"key":"e_1_2_16_47_2","first-page":"34","article-title":"Efficacy and tolerance of adapalene cream 0.1% compared with its cream vehicle for the treatment of acne vulgaris","volume":"68","author":"Lucky A","year":"2001","journal-title":"Cutis"},{"key":"e_1_2_16_48_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2004.10.879"},{"key":"e_1_2_16_49_2","first-page":"145","article-title":"The efficacy and safety of adapalene gel 0.3% in the treatment of acne vulgaris: A randomized, multicenter, investigator\u2010blinded, controlled comparison study versus adapalene gel 0.1% and vehicle","volume":"76","author":"Pariser DM","year":"2005","journal-title":"Cutis"},{"key":"e_1_2_16_50_2","doi-asserted-by":"publisher","DOI":"10.1067\/S0190-9622(03)01152-6"},{"key":"e_1_2_16_51_2","doi-asserted-by":"publisher","DOI":"10.1080\/09546630410021702"},{"key":"e_1_2_16_52_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2007.06.006"},{"key":"e_1_2_16_53_2","first-page":"616","article-title":"Study results of benzoyl peroxide 5%\/clindamycin 1% topical gel, adapalene 0.1% gel, and use in combination for acne vulgaris","volume":"6","author":"Del Rosso JQ","year":"2007","journal-title":"J Drugs Dermatol"},{"key":"e_1_2_16_54_2","doi-asserted-by":"publisher","DOI":"10.1067\/S0190-9622(03)01153-8"},{"key":"e_1_2_16_55_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1540-9740.2005.04279.x"},{"key":"e_1_2_16_56_2","first-page":"349","article-title":"Tazarotene gel is safe and effective in the treatment of acne vulgaris: a multicenter, double\u2010blind, vehicle\u2010controlled study","volume":"63","author":"Shalita AR","year":"1999","journal-title":"Cutis"},{"key":"e_1_2_16_57_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2004.11.012"},{"key":"e_1_2_16_58_2","first-page":"4","article-title":"Efficacy and tolerability of once\u2010daily tazarotene 0.1% gel versus once\u2010daily tretinoin 0.025% gel in the treatment of facial acne vulgaris: a randomized trial","volume":"67","author":"Webster GF","year":"2001","journal-title":"Cutis"},{"key":"e_1_2_16_59_2","first-page":"12","article-title":"Once\u2010daily tazaro\u2010tene 0.1% gel versus once\u2010daily treti\u2010noin 0.1% microsponge gel for the treatment of facial acne vulgaris: a double\u2010blind randomized trial","volume":"69","author":"Leyden JJ","year":"2002","journal-title":"Cutis"},{"key":"e_1_2_16_60_2","first-page":"4","article-title":"A multi\u2010center, double\u2010blind, randomized comparison study of the efficacy and tolerability of once\u2010daily tazarotene 0.1% gel and adapalene 0.1% gel for the treatment of facial acne vulgaris","volume":"69","author":"Webster GF","year":"2002","journal-title":"Cutis"},{"key":"e_1_2_16_61_2","first-page":"153","article-title":"Tazarotene cream versus adapalene cream in the treatment of facial acne vulgaris: a mul\u2010ticenter, double\u2010blind, randomized, parallel\u2010group study","volume":"4","author":"Shalita A","year":"2005","journal-title":"J Drugs Dermatol"},{"key":"e_1_2_16_62_2","first-page":"10","article-title":"Comparison of treatment of acne vulgaris with alternate\u2010day applications of tazarotene 0.1% gel and once\u2010daily applications of adapalene 0.1% gel: a randomized trial","volume":"67","author":"Leyden J","year":"2001","journal-title":"Cutis"},{"key":"e_1_2_16_63_2","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.138.4.481"},{"key":"e_1_2_16_64_2","first-page":"20","article-title":"Optimizing the use of tazarotene for the treatment of facial acne vulgaris through combination therapy","volume":"69","author":"Draelos ZD","year":"2002","journal-title":"Cutis"},{"key":"e_1_2_16_65_2","first-page":"256","article-title":"Tazarotene versus tazarotene plus clindamycin\/ben\u2010zoyl peroxide in the treatment of acne vulgaris: a multicenter, double\u2010blind, randomized parallel\u2010group trial","volume":"5","author":"Tanghetti E","year":"2006","journal-title":"J Drugs Dermatol"},{"key":"e_1_2_16_66_2","doi-asserted-by":"publisher","DOI":"10.1159\/000051376"},{"key":"e_1_2_16_67_2","doi-asserted-by":"publisher","DOI":"10.1159\/000081498"},{"issue":"210","key":"e_1_2_16_68_2","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1159\/000081500","article-title":"Topical retinaldehyde with glycolic acid: study of tolerance and acceptability in association with anti\u2010acne treatments in 1,709 patients","volume":"1","author":"Dr\u00e9no B","year":"2005","journal-title":"Dermatology"},{"key":"e_1_2_16_69_2","doi-asserted-by":"publisher","DOI":"10.1159\/000099593"},{"key":"e_1_2_16_70_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2230.1999.00499.x"},{"key":"e_1_2_16_71_2","doi-asserted-by":"publisher","DOI":"10.1159\/000051381"},{"key":"e_1_2_16_72_2","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.142.5.597"},{"key":"e_1_2_16_73_2","first-page":"45","article-title":"Daily treatment with adapalene gel 0.1% maintains initial improvement of acne vulgaris previously treated with oral lymecycline","volume":"17","author":"Alirezai M","year":"2007","journal-title":"Eur J Dermatol"},{"key":"e_1_2_16_74_2","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.142.5.605"},{"key":"e_1_2_16_75_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(97)70054-9"},{"key":"e_1_2_16_76_2","first-page":"455","article-title":"Cumulative irritancy potential of adapa\u2010lene cream 0.1% compared with adapa\u2010lene gel 0.1% and several tretinoin formulations","volume":"72","author":"Brand B","year":"2003","journal-title":"Cutis"},{"key":"e_1_2_16_77_2","first-page":"238","article-title":"Cumulative irritation potential of adapa\u2010lene 0.1% cream and gel compared with tretinoin microsphere 0.04% and 0.1%","volume":"75","author":"Dosik JS","year":"2005","journal-title":"Cutis"},{"key":"e_1_2_16_78_2","first-page":"289","article-title":"Cumulative irritation potential of adapa\u2010lene 0.1% cream and gel compared with tazarotene cream 0.05% and 0.1%","volume":"75","author":"Dosik JS","year":"2005","journal-title":"Cutis"},{"key":"e_1_2_16_79_2","doi-asserted-by":"publisher","DOI":"10.1067\/S0190-9622(03)01151-4"},{"key":"e_1_2_16_80_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1540-9740.2006.04278.x"},{"key":"e_1_2_16_81_2","first-page":"985","article-title":"Beneficial effect of a moisturizing cream as adjunctive treatment to oral isotretinoin or topical tretinoin in the management of acne","volume":"5","author":"Laquieze S","year":"2006","journal-title":"J Drugs Derma-tol"},{"key":"e_1_2_16_82_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(97)70059-8"},{"key":"e_1_2_16_83_2","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(93)90868-H"},{"key":"e_1_2_16_84_2","doi-asserted-by":"publisher","DOI":"10.1345\/aph.17138"},{"key":"e_1_2_16_85_2","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(93)91004-6"},{"key":"e_1_2_16_86_2","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.a.30744"},{"key":"e_1_2_16_87_2","doi-asserted-by":"publisher","DOI":"10.1016\/0190-9622(91)70065-A"},{"key":"e_1_2_16_88_2","doi-asserted-by":"publisher","DOI":"10.1080\/000155501750208119"},{"key":"e_1_2_16_89_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(97)70050-1"},{"key":"e_1_2_16_90_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.1998.1390s2008.x"},{"key":"e_1_2_16_91_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)63390-9"},{"key":"e_1_2_16_92_2","doi-asserted-by":"publisher","DOI":"10.1067\/mjd.2000.108321"}],"container-title":["JDDG: Journal der Deutschen Dermatologischen Gesellschaft"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1610-0387.2008.06741.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1610-0387.2008.06741.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,16]],"date-time":"2023-10-16T03:14:34Z","timestamp":1697426074000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1610-0387.2008.06741.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,11,25]]},"references-count":91,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2008,12]]}},"alternative-id":["10.1111\/j.1610-0387.2008.06741.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1610-0387.2008.06741.x","archive":["Portico"],"relation":{},"ISSN":["1610-0379","1610-0387"],"issn-type":[{"value":"1610-0379","type":"print"},{"value":"1610-0387","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,11,25]]}}}